#BEGIN_DRUGCARD DB03499

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C4H5O5

# Chemical_IUPAC_Name:
(2R)-3-carboxy-2-hydroxypropanoate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Malate Ion

# HET_ID:
MLT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H6O5/c5-2(4(8)9)1-3(6)7/h2,5H,1H2,(H,6,7)(H,8,9)/p-1/t2-/m1/s1

# InChI_Key:
InChIKey=BJEPYKJPYRNKOW-UWTATZPHSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3499

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
133.0795

# Molecular_Weight_Mono:
133.01369827

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1WWJ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.98

# Predicted_LogS:
0.61

# Predicted_Water_Solubility:
6.13e+02 g/l

# Primary_Accession_No:
DB03499

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754080

# PubChem_Substance_ID:
46504723

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02188

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@H](CC(O)=O)C([O-])=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:19 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
BA000022

# Drug_Target_1_GenBank_ID_Protein:
1653851

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
kaiB

# Drug_Target_1_Gene_Sequence:
>318 bp
ATGAGCCCCTTTAAAAAAACTTACGTTCTCAAACTCTACGTAGCTGGCAACACCCCCAAC
TCTGTGCGGGCCTTAAAAATGCTAAAAAATATCCTTGAGCAAGAATTCCAGGGAGTTTAT
GCCCTCAAAGTAATCGACGTGTTGAAAAATCCCCAATTAGCCGAAGAAGATAAAATTCTT
GCCACCCCCACCTTGGCTAAAATCCTACCGCCCCCTGTCAGGAAAATCATCGGCGACCTT
TCCGACCGAGAGAAAGTATTGATTGGTTTAGACCTGCTCTATGACGAAATTCGGGAACGG
GAAGCAGAAGACCAATAG

# Drug_Target_1_General_Function:
Posttranslational modification, protein turnover, chaperones

# Drug_Target_1_General_References:
8905231	Kaneko T, Sato S, Kotani H, Tanaka A, Asamizu E, Nakamura Y, Miyajima N, Hirosawa M, Sugiura M, Sasamoto S, Kimura T, Hosouchi T, Matsuno A, Muraki A, Nakazaki N, Naruo K, Okumura S, Shimpo S, Takeuchi C, Wada T, Watanabe A, Yamada M, Yasuda M, Tabata S: Sequence analysis of the genome of the unicellular cyanobacterium Synechocystis sp. strain PCC6803. II. Sequence determination of the entire genome and assignment of potential protein-coding regions. DNA Res. 1996 Jun 30;3(3):109-36.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2891

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
11935

# Drug_Target_1_Name:
Circadian clock protein kaiB

# Drug_Target_1_Number_of_Residues:
105

# Drug_Target_1_PDB_ID:
1WWJ

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07689	KaiB

# Drug_Target_1_Protein_Sequence:
>Circadian clock protein kaiB
MSPFKKTYVLKLYVAGNTPNSVRALKMLKNILEQEFQGVYALKVIDVLKNPQLAEEDKIL
ATPTLAKILPPPVRKIIGDLSDREKVLIGLDLLYDEIREREAEDQ

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Component of the kaiABC clock protein complex, which constitutes the main circadian regulator in cyanobacteria. The kaiABC complex may act as a promoter-nonspecific transcription regulator that represses transcription, possibly by acting on the state of chromosome compaction. In the complex, it decreases the phosphorylation status of kaiC. It has no effect on kaiC by itself, but instead needs the presence of both kaiA and kaiC, suggesting that it acts by antagonizing the interaction between kaiA and kaiC

# Drug_Target_1_SwissProt_ID:
P74645

# Drug_Target_1_SwissProt_Name:
KAIB_SYNY3

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
6.84

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X04065

# Drug_Target_2_GenBank_ID_Protein:
41513

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
fumC

# Drug_Target_2_Gene_Sequence:
>1404 bp
ATGAATACAGTACGCAGCGAAAAAGATTCGATGGGGGCGATTGATGTCCCGGCAGATAAG
CTGTGGGGCGCACAAACTCAACGCTCGCTGGAGCATTTCCGCATTTCGACGGAGAAAATG
CCCACCTCACTGATTCATGCGCTGGCGCTAACCAAGCGTGCAGCGGCAAAAGTTAATGAA
GATTTAGGCTTGTTGTCTGAAGAGAAAGCGAGCGCCATTCGTCAGGCGGCGGATGAAGTA
CTGGCAGGACAGCATGACGACGAATTCCCGCTGGCTATCTGGCAGACCGGCTCCGGCACG
CAAAGTAACATGAACATGAACGAAGTGCTGGCTAACCGGGCCAGTGAATTACTCGGCGGT
GTGCGCGGGATGGAACGTAAAGTTCACCCTAACGACGACGTGAACAAAAGCCAAAGTTCC
AACGATGTCTTTCCGACGGCGATGCACGTTGCGGCGCTGCTGGCGCTGCGCAAGCAACTC
ATTCCTCAGCTTAAAACCCTGACACAGACACTGAATGAGAAATCCCGTGCTTTTGCCGAT
ATCGTCAAAATTGGTCGTACTCACTTGCAGGATGCCACGCCGTTAACGCTGGGGCAGGAG
ATTTCCGGCTGGGTAGCGATGCTCGAGCATAATCTCAAACATATCGAATACAGCCTGCCT
CACGTAGCGGAACTGGCTCTTGGCGGTACAGCGGTGGGTACTGGACTAAATACCCATCCG
GAGTATGCGCGTCGCGTAGCAGATGAACTGGCAGTCATTACCTGTGCACCGTTTGTTACC
GCGCCGAACAAATTTGAAGCGCTGGCGACCTGTGATGCCCTGGTTCAGGCGCACGGCGCG
TTGAAAGGGTTGGCTGCGTCACTGATGAAAATCGCCAATGATGTCCGCTGGCTGGCCTCT
GGCCCGCGCTGCGGAATTGGTGAAATCTCAATCCCGGAAAATGAGCCGGGCAGCTCAATC
ATGCCGGGGAAAGTGAACCCAACACAGTGTGAGGCATTAACCATGCTCTGCTGTCAGGTG
ATGGGGAACGACGTGGCGATCAACATGGGGGGCGCTTCCGGTAACTTTGAACTGAACGTC
TTCCGTCCAATGGTGATCCACAATTTCCTGCAATCGGTGCGCTTGCTGGCAGATGGCATG
GAAAGTTTTAACAAACACTGCGCAGTGGGTATTGAACCGAATCGTGAGCGAATCAATCAA
TTACTCAATGAATCGCTGATGCTGGTGACTGCGCTTAACACCCACATTGGTTATGACAAA
GCCGCCGAGATCGCCAAAAAAGCGCATAAAGAAGGGCTGACCTTAAAAGCTGCGGCCCTT
GCGCTGGGGTATCTTAGCGAAGCCGAGTTTGACAGCTGGGTACGGCCAGAACAGATGGTC
GGCAGTATGAAAGCCGGGCGTTAA

# Drug_Target_2_General_Function:
Energy production and conversion

# Drug_Target_2_General_References:
12021453	Estevez M, Skarda J, Spencer J, Banaszak L, Weaver TM: X-ray crystallographic and kinetic correlation of a clinically observed human fumarase mutation. Protein Sci. 2002 Jun;11(6):1552-7.
1917897	Ueda Y, Yumoto N, Tokushige M, Fukui K, Ohya-Nishiguchi H: Purification and characterization of two types of fumarase from Escherichia coli. J Biochem (Tokyo). 1991 May;109(5):728-33.
3005475	Guest JR, Miles JS, Roberts RE, Woods SA: The fumarase genes of Escherichia coli: location of the fumB gene and discovery of a new gene (fumC). J Gen Microbiol. 1985 Nov;131(11):2971-84.
3282546	Woods SA, Schwartzbach SD, Guest JR: Two biochemically distinct classes of fumarase in Escherichia coli. Biochim Biophys Acta. 1988 Apr 28;954(1):14-26.
3541901	Woods SA, Miles JS, Roberts RE, Guest JR: Structural and functional relationships between fumarase and aspartase. Nucleotide sequences of the fumarase (fumC) and aspartase (aspA) genes of Escherichia coli K12. Biochem J. 1986 Jul 15;237(2):547-57.
6328431	Miles JS, Guest JR: Complete nucleotide sequence of the fumarase gene fumA, of Escherichia coli. Nucleic Acids Res. 1984 Apr 25;12(8):3631-42.
8496960	Weaver TM, Levitt DG, Banaszak LJ: Purification and crystallization of fumarase C from Escherichia coli. J Mol Biol. 1993 May 5;231(1):141-4.
8909293	Weaver T, Banaszak L: Crystallographic studies of the catalytic and a second site in fumarase C from Escherichia coli. Biochemistry. 1996 Nov 5;35(44):13955-65.
9097039	Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kasai H, Kashimoto K, Kimura S, Kitakawa M, Kitagawa M, Makino K, Miki T, Mizobuchi K, Mori H, Mori T, Motomura K, Nakade S, Nakamura Y, Nashimoto H, Nishio Y, Oshima T, Saito N, Sampei G, Horiuchi T, et al.: A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map. DNA Res. 1996 Dec 31;3(6):363-77.
9098893	Weaver T, Lees M, Banaszak L: Mutations of fumarase that distinguish between the active site and a nearby dicarboxylic acid binding site. Protein Sci. 1997 Apr;6(4):834-42.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3486

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
50490

# Drug_Target_2_Name:
Fumarate hydratase class II

# Drug_Target_2_Number_of_Residues:
467

# Drug_Target_2_PDB_ID:
1FUO

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00206	Lyase_1

# Drug_Target_2_Protein_Sequence:
>Fumarate hydratase class II
MNTVRSEKDSMGAIDVPADKLWGAQTQRSLEHFRISTEKMPTSLIHALALTKRAAAKVNE
DLGLLSEEKASAIRQAADEVLAGQHDDEFPLAIWQTGSGTQSNMNMNEVLANRASELLGG
VRGMERKVHPNDDVNKSQSSNDVFPTAMHVAALLALRKQLIPQLKTLTQTLNEKSRAFAD
IVKIGRTHLQDATPLTLGQEISGWVAMLEHNLKHIEYSLPHVAELALGGTAVGTGLNTHP
EYARRVADELAVITCAPFVTAPNKFEALATCDALVQAHGALKGLAASLMKIANDVRWLAS
GPRCGIGEISIPENEPGSSIMPGKVNPTQCEALTMLCCQVMGNDVAINMGGASGNFELNV
FRPMVIHNFLQSVRLLADGMESFNKHCAVGIEPNRERINQLLNESLMLVTALNTHIGYDK
AAEIAKKAHKEGLTLKAAALALGYLSEAEFDSWVRPEQMVGSMKAGR

# Drug_Target_2_Reaction:
(S)-malate = fumarate + H2O

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
(S)-malate = fumarate + H(2)O

# Drug_Target_2_SwissProt_ID:
P05042

# Drug_Target_2_SwissProt_Name:
FUMC_ECOLI

# Drug_Target_2_Synonyms:
EC 4.2.1.2
Fumarase C

# Drug_Target_2_Theoretical_pI:
6.57

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasm

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
BX842578

# Drug_Target_3_GenBank_ID_Protein:
1483534

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
glcB

# Drug_Target_3_Gene_Sequence:
>2226 bp
CTAGCGGGCCGCATCGTCACCGGCCCTGTCCGATGGGGCCGGCTTCTCAGCGGCCCGGGC
CTTAAACTCCCGACGACGTCGGTGCAGGATCGGCTCGGTGTAGCCGTTGGGCTGCTGGGC
CCCGGACAAGATCAGCTCCTGCGCGGCCAGGAAGGCGATACTGTCGTCGAAGTTGGGTGC
CATCGGTCGGTATGCCACGTCGCCCGCGTTTTGTCGATCGACCAACGGCGCCATCCGCTC
CAAGCTGGCCCGCACATCCGCGCTGGTGATCACACCGTGGCGCAGCCAGTTGGCCAACAA
TTGGCTGGAGATTCGCAGCGTGGCCCGGTCCTCCATGAGCGCGACGTCGTGGATGTCGGG
CACCTTCGAGCAGCCGACACCTTGATCAACCCAGCGAACCACGTAGCCGAGGATGGATTG
ACAGTTGTTGTCGACCTCTTCGCGGATCTCGTCGGGAGCCCAGGCCAATTCCTTGGCCAG
CGGAATGGTCAGCAATTGTTCGATGGTGGCGCGACGCTTCCCCGCCAGTCCTTGTTGCAC
CGCGGCGACGTCGACCTGGTGGTAGTGCAGCGCATGCAGGGTGGCCGCAGTGGGAGAGGG
AACCCAGGCGGTGCTGGCCCCGGCGCGCGGCTGGGCGATTTTTGTCTCGACCATGTCGGC
CATCAGCTCGGTCATTGTCCACATGCCCTTGCCGACCTGGGCTCGGCCGCTGAACCCGGC
GGCCAGGCCGGCATCGACGTTGTGGTCCTCGTAGGCCAAGATCCACGGCTGGCTCTTCAT
GGTGCCCTTGCGCACCATCGGGCCGGCCTCCATCGAGGTGTGGATTTCATCGCCGGTGCG
GTCCAGGAACCCGGTGTTGATGAACACCACGCGGTCCGCGGCAGCTTTGATGCACGCCTT
GAGGTTGACCGTGGTCCGGCGTTCCTCGTCCATGATGCCGATCTTCATGGTGTTTTGCGG
CAACCCCAGCACATCTTCAACCCGGCTGAACAGTTCGCAGGTAAACGCCACCTCGGCCGG
ACCGTGCATCTTCGGCTTGACGATGTAGATGGAGCCGGTGCGGCTGTTGATCAGCGGCCC
GTTGACGTCGCTGGCCTTTAGCCCGTGGATGGCGATCAGGCCGGTGAATAGGGCATCCAT
GATGCCTTCGAACACCTCGCTGCCGTCAGTGTCGACGATGGCGTCATTCGTCATCAAGTG
ACCGACGTTGCGGACGAACATGAGGCTGCGTCCAGGCAGCGTGAACTGGCCACCGCCGGG
TGCGGTGTAGTTCCGGTCCCTATTGAGCACCCGCAGGAAAGCGGTGCCGTCCTTGTCTAC
CGCTGCTGCCAGGTCGCCCTTGTTCAGGCCGAGCCAGTTCCGATAACCCAGCACCTTGTC
GGCGGCGTCCACGGCGGCCACCGAGTCCTCGAAGTCCATGATCGTGGTGATCGCGGATTC
CAGGATCACGTCCTTGACGCCGGCCCGGTCGGTGGTGCCGACCTGCGACTCCGGATCGAT
CAGGATCTCGATGTGCAAACCGTGATTGATTAGCAGCACCGATGTCGGCGACTCGGCTGC
GCCGGTGTAGCCGGCGAACTGGCCGGGGTTGGCCAGGCCGGTGGACTTATCCGGCAAGGC
AACCACGAGCTGGCCATCCTGCACTGTGAAACCGGTGGCGTCGCCAAAGGAACCCGACGA
CAGCGGAACACTGTCGTCGAGGAACTTGCGGGCATACGCGATCACCTTGTCGCCACGAAC
CTTGTTGTACGTGGGGCCTTTTTCGGCGCCGTCGGTCTCGGGGATGACATCGGTGCCATA
CAAGGCGTCGTAGAGGGAGCCCCAGCGAGCGTTGGCCGCGTTCAGAGCAAACCGCGCGTT
GAGCACCGGCACCACCAGCTGGGGGCCGGCGGTCGTGGTGATCTCAGCGTCGACACCGGA
CGTGGTGATGGTGAAGTCATCAGGTTCGGGAAGCAGGTAGCCGATCTCGGTGAGGAACTG
GCGGTAGGCATCCATGTCGATGGGCTCGATCACCCGACGCCGGTGCCACTTGTCGATCTG
CGCCTGCAGCTCGTCGCGGGCGTTCAACAGAGCTTGGTTCTGCGGGGTCAGGTCGGCGAC
GACCTTGTCGACGCCCGCCCAGAAGCTGTCCGGGTCGATATCGGTGCCAGGCAGGGCTTC
ATTGTTCACGAAGTCGTAGAGCACCCGAGCGATGCGCAAGTTGCCCACCGACACGCGATC
TGTCAT

# Drug_Target_3_General_Function:
Energy production and conversion

# Drug_Target_3_General_References:
12218036	Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, Peterson J, DeBoy R, Dodson R, Gwinn M, Haft D, Hickey E, Kolonay JF, Nelson WC, Umayam LA, Ermolaeva M, Salzberg SL, Delcher A, Utterback T, Weidman J, Khouri H, Gill J, Mikula A, Bishai W, Jacobs Jr WR Jr, Venter JC, Fraser CM: Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol. 2002 Oct;184(19):5479-90.
12393860	Smith CV, Huang CC, Miczak A, Russell DG, Sacchettini JC, Honer zu Bentrup K: Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis. J Biol Chem. 2003 Jan 17;278(3):1735-43. Epub 2002 Oct 21.
9634230	Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE 3rd, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG: Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998 Jun 11;393(6685):537-44.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3190

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
80404

# Drug_Target_3_Name:
Malate synthase G

# Drug_Target_3_Number_of_Residues:
741

# Drug_Target_3_PDB_ID:
1N8W

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01274	Malate_synthase

# Drug_Target_3_Protein_Sequence:
>Malate synthase G
MTDRVSVGNLRIARVLYDFVNNEALPGTDIDPDSFWAGVDKVVADLTPQNQALLNARDEL
QAQIDKWHRRRVIEPIDMDAYRQFLTEIGYLLPEPDDFTITTSGVDAEITTTAGPQLVVP
VLNARFALNAANARWGSLYDALYGTDVIPETDGAEKGPTYNKVRGDKVIAYARKFLDDSV
PLSSGSFGDATGFTVQDGQLVVALPDKSTGLANPGQFAGYTGAAESPTSVLLINHGLHIE
ILIDPESQVGTTDRAGVKDVILESAITTIMDFEDSVAAVDAADKVLGYRNWLGLNKGDLA
AAVDKDGTAFLRVLNRDRNYTAPGGGQFTLPGRSLMFVRNVGHLMTNDAIVDTDGSEVFE
GIMDALFTGLIAIHGLKASDVNGPLINSRTGSIYIVKPKMHGPAEVAFTCELFSRVEDVL
GLPQNTMKIGIMDEERRTTVNLKACIKAAADRVVFINTGFLDRTGDEIHTSMEAGPMVRK
GTMKSQPWILAYEDHNVDAGLAAGFSGRAQVGKGMWTMTELMADMVETKIAQPRAGASTA
WVPSPTAATLHALHYHQVDVAAVQQGLAGKRRATIEQLLTIPLAKELAWAPDEIREEVDN
NCQSILGYVVRWVDQGVGCSKVPDIHDVALMEDRATLRISSQLLANWLRHGVITSADVRA
SLERMAPLVDRQNAGDVAYRPMAPNFDDSIAFLAAQELILSGAQQPNGYTEPILHRRRRE
FKARAAEKPAPSDRAGDDAAR

# Drug_Target_3_Reaction:
acetyl-CoA + H2O + glyoxylate = (S)-malate + CoA

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Acetyl-CoA + H(2)O + glyoxylate = (S)-malate + CoA

# Drug_Target_3_SwissProt_ID:
P0A5J4

# Drug_Target_3_SwissProt_Name:
MASZ_MYCTU

# Drug_Target_3_Synonyms:
EC 2.3.3.9

# Drug_Target_3_Theoretical_pI:
4.83

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Mitochondrion
mitochondrial matrix

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
ME2

# Drug_Target_4_GenBank_ID_Gene:
M55905

# Drug_Target_4_GenBank_ID_Protein:
187300

# Drug_Target_4_GeneCard_ID:
ME2

# Drug_Target_4_Gene_Name:
ME2

# Drug_Target_4_Gene_Sequence:
>1755 bp
ATGTTGTCCCGGTTAAGAGTAGTTTCCACCACTTGTACTTTGGCATGTCGACATTTGCAC
ATAAAAGAAAAAGGCAAGCCACTTATGCTGAACCCAAGAACAAACAAGGGAATGGCATTT
ACTTTACAAGAACGACAAATGCTTGGTCTTCAAGGACTTCTACCTCCCAAAATAGAGACA
CAAGATATTCAAGCCTTACGATTTCATAGAAACTTGAAGAAAATGACTAGCCCTTTGGAA
AAATATATCTACATAATGGGAATACAAGAAAGAAATGAGAAATTGTTTTATAGAATACTG
CAAGATGACATTGAGAGTTTAATGCCAATTGTATATACACCGACGGTTGGTCTTGCCTGC
TCCCAGTATGGACACATCTTTAGAAGACCTAAGGGATTATTTATTTCGATCTCAGACAGA
GGTCATGTTAGATCAATTGTGGATAACTGGCCAGAAAATCATGTTAAGGCTGTTGTAGTG
ACTGATGGAGAGAGAATTCTGGGTCTTGGAGATCTGGGTGTCTATGGAATGGGAATTCCA
GTAGGAAAACTTTGTTTGTATACAGCTTGTGCAGGAATACGGCCTGATAGATGCCTGCCA
GTGTGTATTGATGTGGGAACTGATAATATCGCACTCTTAAAAGACCCATTTTACATGGGC
TTGTACCAGAAACGAGATCGCACACAACAGTATGATGACCTGATTGATGAGTTTATGAAA
GCTATTACTGACAGATATGGCCGGAACACACTCATTCAGTTCGAAGACTTTGGAAATCAT
AATGCATTCAGGTTCTTGAGAAAGTACCGAGAAAAATATTGTACTTTCAATGATGATATT
CAAGGGACAGCTGCAGTAGCTCTAGCAGGTCTTCTTGCAGCACAAAAAGTTATTAGTAAA
CCAATCTCCGAACACAAAATCTTATTCCTTGGAGCAGGAGAGGCTGCTCTTGGAATTGCA
AATCTTATAGTTATGTCTATGGTAGAAAATGGCCTGTCAGAACAAGAGGCACAAAAGAAA
ATCTGGATGTTTGACAAGTATGGTTTATTAGTTAAGGGACGGAAAGCAAAAATAGATAGT
TATCAGGAACCATTTACTCACTCAGCCCCAGAGAGCATACCTGATACTTTTGAAGATGCA
GTGAATATACTGAAGCCTTCAACTATTATTGGAGTTGCAGGTGCTGGCCGTCTTTTCACT
CCTGATGTAATCAGAGCCATGGCCTCTATCAATGAAAGGCCTGTAATATTTGCATTAAGT
AATCCTACAGCACAGGCAGAGTGCACGGCTGAAGAAGCATATACACTTACAGAGGGCAGG
TGTTTGTTTGCCAGTGGCAGTCCATTTGGGCCAGTGAAACTTACAGATGGGCGAGTCTTT
ACACCAGGTCAAGGAAACAATGTTTATATTTTTCCAGGTGTGGCTTTAGCTGTTATTCTC
TGTAACACCCGGCATATTAGTGACAGTGTTTTCCTAGAAGCTGCAAAGGCCCTGACAAGC
CAATTGACAGATGAAGAGCTAGCCCAAGGGAGACTTTACCCACCGCTTGCTAATATTCAG
GAAGTTTCTATTAACATTGCTATTAAAGTTACAGAATACCTATATGCTAATAAAATGGCT
TTCCGATACCCAGAACCTGAAGACAAGGCCAAATATGTTAAAGAAAGAACATGGCGGAGT
GAATATGATTCCCTGCTGCCAGATGTGTATGAATGGCCAGAATCTGCATCAAGCCCTCCT
GTGATAACAGAATAG

# Drug_Target_4_General_Function:
Energy production and conversion

# Drug_Target_4_General_References:
11401430	Yanaihara N, Kohno T, Takakura S, Takei K, Otsuka A, Sunaga N, Takahashi M, Yamazaki M, Tashiro H, Fukuzumi Y, Fujimori Y, Hagiwara K, Tanaka T, Yokota J: Physical and transcriptional map of a 311-kb segment of chromosome 18q21, a candidate lung tumor suppressor locus. Genomics. 2001 Mar 1;72(2):169-79.
12121650	Yang Z, Lanks CW, Tong L: Molecular mechanism for the regulation of human mitochondrial NAD(P)+-dependent malic enzyme by ATP and fumarate. Structure. 2002 Jul;10(7):951-60.
12665801	Gevaert K, Goethals M, Martens L, Van Damme J, Staes A, Thomas GR, Vandekerckhove J: Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol. 2003 May;21(5):566-9. Epub 2003 Mar 31.
12962632	Tao X, Yang Z, Tong L: Crystal structures of substrate complexes of malic enzyme and insights into the catalytic mechanism. Structure. 2003 Sep;11(9):1141-50.
1993674	Loeber G, Infante AA, Maurer-Fogy I, Krystek E, Dworkin MB: Human NAD(+)-dependent mitochondrial malic enzyme. cDNA cloning, primary structure, and expression in Escherichia coli. J Biol Chem. 1991 Feb 15;266(5):3016-21.

# Drug_Target_4_HGNC_ID:
HGNC:6984

# Drug_Target_4_HPRD_ID:
01103

# Drug_Target_4_ID:
166

# Drug_Target_4_Locus:
6p25-p24|18q21

# Drug_Target_4_Molecular_Weight:
65444

# Drug_Target_4_Name:
NAD-dependent malic enzyme, mitochondrial

# Drug_Target_4_Number_of_Residues:
584

# Drug_Target_4_PDB_ID:
1QR6

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00390	malic
PF03949	Malic_M

# Drug_Target_4_Protein_Sequence:
>NAD-dependent malic enzyme, mitochondrial precursor
MLSRLRVVSTTCTLACRHLHIKEKGKPLMLNPRTNKGMAFTLQERQMLGLQGLLPPKIET
QDIQALRFHRNLKKMTSPLEKYIYIMGIQERNEKLFYRILQDDIESLMPIVYTPTVGLAC
SQYGHIFRRPKGLFISISDRGHVRSIVDNWPENHVKAVVVTDGERILGLGDLGVYGMGIP
VGKLCLYTACAGIRPDRCLPVCIDVGTDNIALLKDPFYMGLYQKRDRTQQYDDLIDEFMK
AITDRYGRNTLIQFEDFGNHNAFRFLRKYREKYCTFNDDIQGTAAVALAGLLAAQKVISK
PISEHKILFLGAGEAALGIANLIVMSMVENGLSEQEAQKKIWMFDKYGLLVKGRKAKIDS
YQEPFTHSAPESIPDTFEDAVNILKPSTIIGVAGAGRLFTPDVIRAMASINERPVIFALS
NPTAQAECTAEEAYTLTEGRCLFASGSPFGPVKLTDGRVFTPGQGNNVYIFPGVALAVIL
CNTRHISDSVFLEAAKALTSQLTDEELAQGRLYPPLANIQEVSINIAIKVTEYLYANKMA
FRYPEPEDKAKYVKERTWRSEYDSLLPDVYEWPESASSPPVITE

# Drug_Target_4_Reaction:
(S)-malate + NAD+ = pyruvate + CO2 + NADH

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Not Available

# Drug_Target_4_SwissProt_ID:
P23368

# Drug_Target_4_SwissProt_Name:
MAOM_HUMAN

# Drug_Target_4_Synonyms:
EC 1.1.1.38
Malic enzyme 2
NAD-ME
NAD-dependent malic enzyme, mitochondrial precursor

# Drug_Target_4_Theoretical_pI:
7.67

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
CS

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
6969

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Citrate synthase, mitochondrial

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
O75390

# Drug_Target_5_SwissProt_Name:
CISY_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
Not Available

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
U40740

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
synC

# Drug_Target_6_Gene_Sequence:
>1050 bp
ATGCAAAACAACAACGAATTTAAAATTGGTAATCGTTCAGTAGGTTACAACCACGAACCA
TTGATTATCTGTGAAATCGGCATCAATCATGAAGGCTCTTTAAAAACAGCTTTTGAAATG
GTTGATGCTGCCTATAATGCAGGCGCTGAAGTTGTTAAACATCAAACACACATCGTTGAA
GACGAAATGTCTGATGAGGCCAAACAAGTCATTCCAGGCAATGCAGATGTCTCTATTTAT
GAAATTATGGAACGTTGCGCCCTGAATGAAGAAGATGAGATTAAATTAAAAGAATACGTA
GAGAGTAAGGGTATGATTTTTATCAGTACTCCTTTCTCTCGTGCAGCTGCTTTACGATTA
CAACGTATGGATATTCCAGCATATAAAATCGGCTCTGGCGAATGTAATAACTACCCATTA
ATTAAACTGGTGGCCTCTTTTGGTAAGCCTATTATTCTCTCTACCGGCATGAATTCTATT
GAAAGCATCAAAAAGTCGGTAGAAATTATTCGAGAAGCAGGGGTACCTTATGCTTTGCTT
CACTGTACCAACATCTACCCAACCCCTTACGAAGATGTTCGATTGGGTGGTATGAACGAT
TTATCTGAAGCCTTTCCAGACGCAATCATTGGCCTGTCTGACCATACCTTAGATAACTAT
GCTTGCTTAGGAGCAGTAGCTTTAGGCGGTTCGATTTTAGAGCGTCACTTTACTGACCGC
ATGGATCGCCCAGGTCCGGATATTGTATGCTCTATGAATCCGGATACTTTTAAAGAGCTC
AAGCAAGGCGCTCATGCTTTAAAATTGGCACGCGGCGGCAAAAAAGACACGATTATCGCG
GGAGAAAAGCCAACTAAAGATTTCGCCTTTGCATCTGTCGTAGCAGATAAAGACATTAAA
AAAGGAGAACTGTTGTCCGGAGATAACCTATGGGTTAAACGCCCAGGCAATGGAGACTTC
AGCGTCAACGAATATGAAACATTATTTGGTAAGGTCGCTGCTTGCAATATTCGCAAAGGT
GCTCAAATCAAAAAAACTGATATTGAATAA

# Drug_Target_6_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_6_General_References:
1659649	Frosch M, Edwards U, Bousset K, Krausse B, Weisgerber C: Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides. Mol Microbiol. 1991 May;5(5):1251-63.
8763931	Swartley JS, Ahn JH, Liu LJ, Kahler CM, Stephens DS: Expression of sialic acid and polysialic acid in serogroup B Neisseria meningitidis: divergent transcription of biosynthesis and transport operons through a common promoter region. J Bacteriol. 1996 Jul;178(14):4052-9.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
4384

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
38348

# Drug_Target_6_Name:
Capsule biosynthesis protein

# Drug_Target_6_Number_of_Residues:
349

# Drug_Target_6_PDB_ID:
1XUZ

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF03102	NeuB

# Drug_Target_6_Protein_Sequence:
>Capsule biosynthesis protein
MQNNNEFKIGNRSVGYNHEPLIICEIGINHEGSLKTAFEMVDAAYNAGAEVVKHQTHIVE
DEMSDEAKQVIPGNADVSIYEIMERCALNEEDEIKLKEYVESKGMIFISTPFSRAAALRL
QRMDIPAYKIGSGECNNYPLIKLVASFGKPIILSTGMNSIESIKKSVEIIREAGVPYALL
HCTNIYPTPYEDVRLGGMNDLSEAFPDAIIGLSDHTLDNYACLGAVALGGSILERHFTDR
MDRPGPDIVCSMNPDTFKELKQGAHALKLARGGKKDTIIAGEKPTKDFAFASVVADKDIK
KGELLSGDNLWVKRPGNGDFSVNEYETLFGKVAACNIRKGAQIKKTDIE

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
Q57265

# Drug_Target_6_SwissProt_Name:
Q57265_NEIME

# Drug_Target_6_Synonyms:
SiaC

# Drug_Target_6_Theoretical_pI:
5.18

# Drug_Target_6_Transmembrane_Regions:
None

#END_DRUGCARD DB03499
